306 related articles for article (PubMed ID: 32004406)
1. Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Garg S; Unnithan R; Hansen KE; Costedoat-Chalumeau N; Bartels CM
Arthritis Care Res (Hoboken); 2021 May; 73(5):707-716. PubMed ID: 32004406
[TBL] [Abstract][Full Text] [Related]
2. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
[TBL] [Abstract][Full Text] [Related]
4. Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
Yeon Lee J; Lee J; Ki Kwok S; Hyeon Ju J; Su Park K; Park SH
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):536-542. PubMed ID: 27390146
[TBL] [Abstract][Full Text] [Related]
5. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
[TBL] [Abstract][Full Text] [Related]
6. The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Miyagawa I; Nakano K; Nakayamada S; Iwata S; Hanami K; Fukuyo S; Kubo S; Kawabe A; Miyazaki Y; Inoue Y; Ueno M; Ohkubo N; Fujita Y; Tanaka Y
Int J Rheum Dis; 2020 Apr; 23(4):549-558. PubMed ID: 32020727
[TBL] [Abstract][Full Text] [Related]
7. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.
Feldman CH; Collins J; Zhang Z; Subramanian SV; Solomon DH; Kawachi I; Costenbader KH
Semin Arthritis Rheum; 2018 Oct; 48(2):205-213. PubMed ID: 29458974
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
[TBL] [Abstract][Full Text] [Related]
9. Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus Erythematosus.
Petri M; Konig MF; Li J; Goldman DW
Arthritis Rheumatol; 2021 Jun; 73(6):997-1004. PubMed ID: 33403833
[TBL] [Abstract][Full Text] [Related]
10. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
Carmichael SJ; Day RO; Tett SE
Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
[TBL] [Abstract][Full Text] [Related]
11. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus.
Costedoat-Chalumeau N; Amoura Z; Hulot JS; Aymard G; Leroux G; Marra D; Lechat P; Piette JC
Ann Rheum Dis; 2007 Jun; 66(6):821-4. PubMed ID: 17324970
[TBL] [Abstract][Full Text] [Related]
12. Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
Feldman CH; Yazdany J; Guan H; Solomon DH; Costenbader KH
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1712-21. PubMed ID: 26097166
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence.
Blanchet B; Jallouli M; Allard M; Ghillani-Dalbin P; Galicier L; Aumaître O; Chasset F; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Goulvestre C; Hulot JS; Amoura Z; Vidal M; Piette JC; ; Jourde-Chiche N; Costedoat-Chalumeau N
Arthritis Res Ther; 2020 Sep; 22(1):223. PubMed ID: 32977856
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.
Balevic SJ; Cohen-Wolkowiez M; Eudy AM; Green TP; Schanberg LE; Clowse MEB
J Rheumatol; 2019 Jan; 46(1):57-63. PubMed ID: 30275257
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
Morita S; Takahashi T; Yoshida Y; Yokota N
Ther Drug Monit; 2016 Apr; 38(2):259-67. PubMed ID: 26587870
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus.
Ting TV; Kudalkar D; Nelson S; Cortina S; Pendl J; Budhani S; Neville J; Taylor J; Huggins J; Drotar D; Brunner HI
J Rheumatol; 2012 Jan; 39(1):174-9. PubMed ID: 22089460
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
Noé G; Amoura Z; Combarel D; Lori L; Tissot N; Seycha A; Funck-Brentano C; Zahr N
Ther Drug Monit; 2019 Aug; 41(4):476-482. PubMed ID: 30807538
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
[TBL] [Abstract][Full Text] [Related]
19. Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus.
Yoshida M; Minowa K; Amano H; Asai Y; Yamaji K; Tamura N
Lupus; 2021 Aug; 30(9):1378-1384. PubMed ID: 33966540
[TBL] [Abstract][Full Text] [Related]
20. Adherence to treatment in systemic lupus erythematosus patients.
Costedoat-Chalumeau N; Pouchot J; Guettrot-Imbert G; Le Guern V; Leroux G; Marra D; Morel N; Piette JC
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):329-40. PubMed ID: 24238690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
